Skip to content
Accessibility help
Search NICE…
Skip to content
Menu
Sign in
Guidance
Standards and indicators
Life sciences
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
About
Home
NICE guidance
Published
Published: Guidance, quality standards and advice
Skip to filters
Skip to results
Published
In consultation
In development
Awaiting development
Topic selection
Filter
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
Antimicrobial prescribing (39)
COVID-19 (12)
Type
Type
Guidance (1898)
NICE advice (321)
Quality standard (198)
Guidance programme
Guidance programme
Antimicrobial prescribing guidelines (20)
Cancer service guidelines (8)
Clinical guidelines (225)
COVID-19 rapid guidelines (3)
Diagnostics guidance (50)
Health technology evaluations (18)
Highly specialised technologies guidance (28)
Interventional procedures guidance (603)
Medical technologies guidance (67)
Medicines practice guidelines (5)
NICE guidelines (341)
Public health guidelines (61)
Safe staffing guidelines (2)
Social care guidelines (71)
Technology appraisal guidance (791)
Advice programme
Advice programme
Evidence summaries (68)
Medtech innovation briefings (253)
Apply filters
Showing 501 to 550 of 2417
Sort by
Date
Title
Apply sorting
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults
NG215
20 April 2022
20 April 2022
Daratumumab monotherapy for treating relapsed and refractory multiple myeloma
TA783
13 April 2022
13 April 2022
Stroke and transient ischaemic attack in over 16s: diagnosis and initial management
NG128
1 May 2019
13 April 2022
myCOPD for managing chronic obstructive pulmonary disease
MTG68
31 March 2022
31 March 2022
UroShield for preventing catheter-associated urinary tract infections
MTG69
31 March 2022
31 March 2022
Diabetes in children and young people
QS125
14 July 2016
31 March 2022
Sotorasib for previously treated KRAS G12C mutation-positive advanced non-small-cell lung cancer
TA781
30 March 2022
30 March 2022
Tagraxofusp for treating blastic plasmacytoid dendritic cell neoplasm (terminated appraisal)
TA782
30 March 2022
30 March 2022
Freelite assays for diagnosing multiple myeloma and related conditions (terminated assessment)
DG47
30 March 2022
30 March 2022
Liposuction for chronic lipoedema
IPG721
29 March 2022
29 March 2022
icobrain ms for active relapsing–remitting multiple sclerosis
MIB291
29 March 2022
29 March 2022
Joint replacement (primary): hip, knee and shoulder
QS206
29 March 2022
29 March 2022
Atidarsagene autotemcel for treating metachromatic leukodystrophy
HST18
28 March 2022
28 March 2022
Nivolumab with ipilimumab for untreated advanced renal cell carcinoma
TA780
24 March 2022
24 March 2022
Neonatal parenteral nutrition
QS205
22 March 2022
22 March 2022
Dostarlimab for previously treated advanced or recurrent endometrial cancer with high microsatellite instability or mismatch repair deficiency
TA779
16 March 2022
16 March 2022
Integrated health and social care for people experiencing homelessness
NG214
16 March 2022
16 March 2022
Fetal alcohol spectrum disorder
QS204
16 March 2022
16 March 2022
SecurePort IV tissue adhesive for use with percutaneous catheters
MIB288
15 March 2022
15 March 2022
Otitis media (acute): antimicrobial prescribing
NG91
28 March 2018
11 March 2022
Lenalidomide for relapsed or refractory mantle cell lymphoma (terminated appraisal)
TA774
9 March 2022
9 March 2022
Empagliflozin for treating chronic heart failure with reduced ejection fraction
TA773
9 March 2022
9 March 2022
Dapagliflozin for treating chronic kidney disease
TA775
9 March 2022
9 March 2022
Pitolisant hydrochloride for treating excessive daytime sleepiness caused by obstructive sleep apnoea
TA776
9 March 2022
9 March 2022
Solriamfetol for treating excessive daytime sleepiness caused by obstructive sleep apnoea
TA777
9 March 2022
9 March 2022
Pegcetacoplan for treating paroxysmal nocturnal haemoglobinuria
TA778
9 March 2022
9 March 2022
Percutaneous insertion of a cystic duct stent after cholecystostomy for acute calculous cholecystitis
IPG720
9 March 2022
9 March 2022
Prontosan for treating acute and chronic wounds
MTG67
8 March 2022
8 March 2022
3C Patch for treating diabetic foot ulcers
MTG66
7 March 2022
7 March 2022
Endoscopic full thickness removal of gastrointestinal stromal tumours of the stomach
IPG717
2 March 2022
2 March 2022
Intramedullary distraction for lower limb lengthening
IPG718
2 March 2022
2 March 2022
Endoscopic balloon dilation for subglottic or tracheal stenosis
IPG719
2 March 2022
2 March 2022
Mental wellbeing at work
NG212
2 March 2022
2 March 2022
Lumella point-of-care test for assessing pre-eclampsia risk
MIB287
1 March 2022
1 March 2022
Pembrolizumab for treating relapsed or refractory classical Hodgkin lymphoma after stem cell transplant or at least 2 previous therapies
TA772
23 February 2022
23 February 2022
PredictSURE IBD and IBDX to guide treatment of Crohn's disease
DG45
23 February 2022
23 February 2022
EarlyCDT Lung for assessing risk of lung cancer in solid lung nodules
DG46
23 February 2022
23 February 2022
Odevixibat for treating progressive familial intrahepatic cholestasis
HST17
22 February 2022
22 February 2022
The Insides System for managing intestinal failure
MIB286
17 February 2022
17 February 2022
Pembrolizumab with carboplatin and paclitaxel for untreated metastatic squamous non-small-cell lung cancer
TA770
9 February 2022
9 February 2022
Daratumumab with bortezomib, melphalan and prednisone for untreated multiple myeloma (terminated appraisal)
TA771
9 February 2022
9 February 2022
d-Nav insulin management app for type 2 diabetes
MIB285
8 February 2022
8 February 2022
Olaparib for treating BRCA mutation-positive HER2-negative metastatic breast cancer after chemotherapy (terminated appraisal)
TA762
2 February 2022
2 February 2022
Daratumumab in combination for untreated multiple myeloma when a stem cell transplant is suitable
TA763
2 February 2022
2 February 2022
Fremanezumab for preventing migraine
TA764
2 February 2022
2 February 2022
Venetoclax with azacitidine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitable
TA765
2 February 2022
2 February 2022
Pembrolizumab for adjuvant treatment of completely resected stage 3 melanoma
TA766
2 February 2022
2 February 2022
Ponesimod for treating relapsing–remitting multiple sclerosis
TA767
2 February 2022
2 February 2022
Upadacitinib for treating active psoriatic arthritis after inadequate response to DMARDs
TA768
2 February 2022
2 February 2022
Palforzia for treating peanut allergy in children and young people
TA769
2 February 2022
2 February 2022
Previous page
1
…
9
10
Current page
11
12
13
…
49
Page
11
of
49
Next page
Results per page
10
25
50
All
Back to top